Sesh

Early-stage cancer detection still relies on invasive biopsies and imprecise imaging. Sesh is developing a precision immuno-oncology liquid biopsy — a blood test that maps cancer-specific biomarkers to detect disease earlier, monitor treatment response, and guide therapeutic decisions with a simple blood draw.